Johns Hopkins-born pharma company raising $40.5 million, hunting for lab space

A Baltimore biotechnology company is raising up to $40.5 million and working to develop pharmaceutical technology born out of Johns Hopkins University. Dracen Pharmaceuticals Inc. is working to develop technologies conceptualized by Barbara Slusher, a professor of neurology, and Dr. Jonathan Powell, a professor of oncology at Johns Hopkins School of Medicine. Dracen has entered an exclusive agreement with Hopkins and the Institute of Organic Chem istry and Biochemistry in Prague to license the jointly-owned…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news